Nkarta, INC Form 4 insider transactions

Nkarta, Inc. reports that Director Ali Behbahani acquired stock options for 37,000 shares of common stock.

Nkarta, Inc. reports that Director George Simeon acquired stock options for 37,000 shares of common stock.

Nkarta, Inc. Director George Vratsanos reported the acquisition of stock options for 37,000 shares of common stock.

Nkarta, Inc. reports that Director Zachary Scheiner was granted a stock option for 37,000 shares with an exercise price of $2.46.

Nkarta, Inc. reports that Director Leone D. Patterson was granted stock options for 37,000 shares.

Nkarta, Inc. reports that Director Michael Dybbs acquired 37,000 stock options with an exercise price of $2.46.

Nkarta, Inc. reports a Form 4 filing detailing stock option transactions by Director Angela Thedinga.

Nkarta, Inc. CEO Paul J Hastings sold 26,046 shares of common stock at $2.07 per share to cover tax withholding obligations related to vested Restricted Stock Units.

Nkarta Inc. President Nadir Mahmood sold 5,649 shares of common stock on January 15, 2026, to cover tax withholding obligations related to vested Restricted Stock Units.

Nkarta's Chief Medical Officer, Shawn Marshall Rose, received 70,000 Restricted Stock Units and 139,000 stock options.

Nkarta President Nadir Mahmood acquired 80,000 Restricted Stock Units and 160,000 stock options, signaling increased long-term alignment with the company.

Nkarta, Inc. CEO Paul J. Hastings acquired 94,000 Restricted Stock Units and 562,000 stock options, increasing his beneficial ownership.

Nkarta, Inc. has granted 500,000 stock options to Shawn Marshall Rose, Chief Medical Officer and Head of Research & Development, with an exercise price of $1.75 per share.

Nkarta, Inc. CEO Paul Hastings reported a non-discretionary sale of 1,790 common shares to cover tax withholding from Restricted Stock Unit vesting, while also acquiring 2,000 shares through the company's Employee Stock Purchase Plan.

Nkarta, Inc. Director George Vratsanos was granted 46,000 stock options with an exercise price of $1.83 per share, aligning his interests with the company's long-term performance.

Nkarta, Inc. Director Simeon George was granted 46,000 stock options with an exercise price of $1.83, aligning his interests with shareholder value.

Nkarta, Inc. Director Ali Behbahani was granted 46,000 stock options with an exercise price of $1.83, vesting fully by June 5, 2026, or earlier under specific conditions.

RA Capital Management, L.P. and its affiliated funds, along with managing members, reported the grant of 46,000 stock options in Nkarta, Inc. to Dr. Zachary Scheiner, a Principal of RA Capital and a director on Nkarta's board, with an exercise price of $1.83 per share.

Nkarta, Inc. President Nadir Mahmood was granted 123,500 stock options with an exercise price of $1.83, vesting over two years.

Nkarta, Inc. CEO and Director Paul J. Hastings was granted 377,000 stock options with an exercise price of $1.83, vesting over two years, as detailed in a recent SEC Form 4 filing.

Nkarta, Inc. Director Angela Thedinga was granted 46,000 stock options with an exercise price of $1.83, aligning her interests with shareholder value.

Nkarta, Inc. Director and 10% Owner Zachary Scheiner was granted 46,000 stock options with an exercise price of $1.83, but disclaims personal beneficial ownership as the options are held for the benefit of RA Capital funds.

Nkarta, Inc. Director Leone Patterson was granted 46,000 stock options with an exercise price of $1.83, vesting fully by June 5, 2026, or earlier under certain conditions.

Nkarta, Inc. Director Michael Dybbs was granted 46,000 stock options with an exercise price of $1.83, aligning his interests with the company's long-term performance.

David Shook, Chief Medical Officer at Nkarta, Inc., sold 8,638 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Alyssa Levin, Chief Financial and Business Officer at Nkarta, sold 5,838 shares of common stock to cover tax obligations related to vesting of restricted stock units.

Nkarta Inc.'s Chief Technical Officer, Ralph Brandenberger, sold 7,447 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Nkarta's CEO, Paul J. Hastings, sold 17,378 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Nkarta Inc.'s Chief Legal Officer, Alicia J. Hager, sold 9,584 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Alyssa Levin, Chief Financial and Business Officer of Nkarta, Inc., reports acquisition of stock options and restricted stock units.